These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35125335)

  • 1. Retrospective analysis of VES-13 questionnaires in the Senior Women's Breast Cancer Clinic at Sunnybrook Health Sciences, Toronto, Ontario, Canada.
    Zereshkian A; Khan BM; Cao X; Henry-Noel N; Menjak I; Mehta R; Bristow B; Trudeau M; Neve M; Norris M; Pasetka M; Rice K; McCullock F; Wright F; Szumacher E
    J Geriatr Oncol; 2022 May; 13(4):541-544. PubMed ID: 35125335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the Vulnerable Elders Survey 13 screening tool in identifying cancer treatment modification after geriatric assessment in pre-treatment patients: A retrospective analysis.
    Rowbottom L; Loucks A; Jin R; Breunis H; Syed AT; Watt S; Timilshina N; Puts M; Yokom D; Berger A; Alibhai SMH
    J Geriatr Oncol; 2019 Mar; 10(2):229-234. PubMed ID: 30420323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gait Speed vs. VES-13: A Pilot Study Comparing Screening Tools to Determine the Need for a Comprehensive Geriatric Assessment in Senior Women with Breast Cancer.
    Hollenberg DC; Menjak IB; Mehta R; Bristow B; Trudeau ME; Gibson L; Neve M; Norris M; Pasetka M; Rice K; McCullock F; Wright FC; Szumacher E
    J Med Imaging Radiat Sci; 2019 Dec; 50(4):551-556. PubMed ID: 31780434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Perceptions and Expectations of Older Women in the Establishment of the Senior Women's Breast Cancer Clinic (SWBCC): a Needs Assessment Study.
    Tjong MC; Menjak I; Trudeau M; Mehta R; Wright F; Leahey A; Ellis J; Gallagher D; Gibson L; Bristow B; Rice K; Szumacher E
    J Cancer Educ; 2017 Dec; 32(4):850-857. PubMed ID: 27142360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancer.
    Shah M; Noronha V; Ramaswamy A; Gattani S; Mokal S; Joshi A; Patil V; Menon N; Banavali S; Badwe R; Prabhash K
    J Geriatr Oncol; 2022 Jun; 13(5):720-730. PubMed ID: 35283049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vulnerable elders survey and socioeconomic status predict functional decline and death among older women with newly diagnosed nonmetastatic breast cancer.
    Owusu C; Margevicius S; Schluchter M; Koroukian SM; Schmitz KH; Berger NA
    Cancer; 2016 Aug; 122(16):2579-86. PubMed ID: 27348765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy - The randomized NORDIC9-study.
    Liposits G; Ryg J; Skuladottir H; Winther SB; Möller S; Hofsli E; Shah CH; Poulsen LØ; Berglund Å; Qvortrup C; Osterlund P; Glimelius B; Sorbye H; Pfeiffer P
    J Geriatr Oncol; 2023 Jan; 14(1):101408. PubMed ID: 36494261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancer.
    Cavdar E; Iriagac Y; Karaboyun K; Avci O; Seber ES
    J Geriatr Oncol; 2022 Jul; 13(6):821-827. PubMed ID: 35361561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the vulnerable elders survey-13 screening tool in predicting treatment plan modification for older adults with cancer.
    Almugbel FA; Timilshina N; AlQurini N; Loucks A; Jin R; Berger A; Romanovsky L; Puts M; Alibhai SMH
    J Geriatr Oncol; 2021 Jun; 12(5):786-792. PubMed ID: 33342723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation.
    Mohile SG; Bylow K; Dale W; Dignam J; Martin K; Petrylak DP; Stadler WM; Rodin M
    Cancer; 2007 Feb; 109(4):802-10. PubMed ID: 17219443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of a geriatric oncology service at the Royal Marsden Hospital.
    Mac Eochagain C; Barrell A; Slavova-Boneva V; Murphy J; Pattwell M; Cumming J; Edmondson A; McGinn M; Kipps E; Milton M; Jethwa J; Ring A; Battisti NML
    J Geriatr Oncol; 2024 Mar; 15(2):101698. PubMed ID: 38219333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The VES-13 and G-8 tools as predictors of toxicity associated with aromatase inhibitors in the adjuvant treatment of breast cancer in elderly patients: A single-center study.
    Irelli A; Sirufo MM; Scipioni T; Aielli F; Martella F; Ginaldi L; Pancotti A; Martinis M
    Indian J Cancer; 2022; 59(4):485-492. PubMed ID: 36861519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional decline and resilience in older adults over the age of 70 receiving radiotherapy for breast cancer: A pilot study.
    Akkila S; Mahal S; Dawdy K; Cao X; Szumacher E
    J Geriatr Oncol; 2023 Apr; 14(3):101476. PubMed ID: 36989937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.
    Soubeyran P; Bellera C; Goyard J; Heitz D; Curé H; Rousselot H; Albrand G; Servent V; Jean OS; van Praagh I; Kurtz JE; Périn S; Verhaeghe JL; Terret C; Desauw C; Girre V; Mertens C; Mathoulin-Pélissier S; Rainfray M
    PLoS One; 2014; 9(12):e115060. PubMed ID: 25503576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The linear relationship between the Vulnerable Elders Survey-13 score and mortality in an Asian population of community-dwelling older persons.
    Wang J; Lin W; Chang LH
    Arch Gerontol Geriatr; 2018 Jan; 74():32-38. PubMed ID: 28957686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the French version of the Vulnerable Elders Survey-13 (VES-13).
    Belmin J; Khellaf L; Pariel S; Jarzebowski W; Valembois L; Zeisel J; Lafuente-Lafuente C
    BMC Med Res Methodol; 2020 Feb; 20(1):21. PubMed ID: 32024470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Frailty and Risk of Chemotherapy Toxicity at a Geriatric-Oncology Multidisciplinary Clinic.
    Raza S; Rudolph JL; Mujahid N; Neupane I; Monteiro JFG; Singh M; Khurshid H
    R I Med J (2013); 2023 May; 106(4):13-18. PubMed ID: 37098141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Frailty in Older Patients With Early-Stage Solid Tumors: A Prospective Longitudinal Evaluation of Three Different Geriatric Tools.
    Biganzoli L; Mislang AR; Di Donato S; Becheri D; Biagioni C; Vitale S; Sanna G; Zafarana E; Gabellini S; Del Monte F; Mori E; Pozzessere D; Brunello A; Luciani A; Laera L; Boni L; Di Leo A; Mottino G
    J Gerontol A Biol Sci Med Sci; 2017 Jul; 72(7):922-928. PubMed ID: 28158486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two frailty screening tools in older women with early breast cancer.
    Molina-Garrido MJ; Guillen-Ponce C
    Crit Rev Oncol Hematol; 2011 Jul; 79(1):51-64. PubMed ID: 20663685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher vulnerable elders survey scores predict death and functional decline in vulnerable older people.
    Min LC; Elliott MN; Wenger NS; Saliba D
    J Am Geriatr Soc; 2006 Mar; 54(3):507-11. PubMed ID: 16551321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.